News

‘Spotify’s COVID problems are bigger than Joe Rogan’ -The Verge

https://www.theverge.com/2022/2/15/22934779/spotify-covid-vaccine-music-moderation-hot-pod?utm_campaign=theverge&utm_content=chorus&utm_medium=social&utm_source=twitter

byBenzinga Newsdesk

February 15, 2022

1 minute read

https://www.theverge.com/2022/2/15/22934779/spotify-covid-vaccine-music-moderation-hot-pod?utm_campaign=theverge&utm_content=chorus&utm_medium=social&utm_source=twitter

Goldman Sachs Maintains Buy on Weatherford International, Raises Price Target to $38

By Benzinga Newsdesk

Today, 10:34 PM

Goldman Sachs analyst Atidrip Modak maintains Weatherford International (NASDAQ:WFRD) with a Buy and raises the price target from $30 to $38.

WFRD

Flower One Joins Other Cannabis Companies In Delaying Annual Financial Statements

By Vuk Zdinjak

Today, 10:34 PM

Flower One Holdings Inc. (OTCQX: FLOOF) (CSE:FONE) (FSE:F11) will have a delay in the filing of its financial statements for the financial year ended December 31, 2021, the accompanying management’s discussion and analysis, and certificates of its CEO and CFO until after the deadline.

CSE:FONE

Jacobs Engineering Appointed East West Rail Program Partner

By Akanksha

Today, 10:34 PM

Jacobs Engineering Group Inc (NYSE:J) agreed to the role as the East West Rail program partner for providing…

Mersana Stock Gains On FDA Orphan Drug Designation For Gastric Cancer Drug

By Ragothaman Srinivasan

Today, 10:34 PM

Mersana Therapeutics, Inc. (NASDAQ: MRSN) received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its drug candidate XMT-2056 or the treatment of gastric cancer. The company is planning to start a clinical study evaluating XMT-2056 for gastric and other cancers.

MRSN

‘Spotify’s COVID problems are bigger than Joe Rogan’ -The Verge

Related Posts

Goldman Sachs Maintains Buy on Weatherford International, Raises Price Target to $38

Flower One Joins Other Cannabis Companies In Delaying Annual Financial Statements

Jacobs Engineering Appointed East West Rail Program Partner

Mersana Stock Gains On FDA Orphan Drug Designation For Gastric Cancer Drug